Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.20.4
Segment Information (Tables)
 3 Months Ended
Dec. 27, 2020
Segment Reporting [Abstract]  
Revenues, EBT, and Assets for reportable segments
The table below presents revenues and EBT for reportable segments (in millions):
Three Months Ended
December 27,
2020		 December 29,
2019
Revenues
QCT $ 6,533  $ 3,618 
QTL 1,660  1,404 
QSI 9  20 
Reconciling items 33  35 
Total $ 8,235  $ 5,077 
EBT
QCT $ 1,919  $ 479 
QTL 1,270  1,017 
QSI 158  (3)
Reconciling items (743) (546)
Total $ 2,604  $ 947 
Reconciling items for reportable segments - revenues
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months Ended
December 27,
2020		 December 29,
2019
Revenues
Nonreportable segments $ 33  $ 35 
$ 33  $ 35 
EBT
Unallocated cost of revenues $ (74) $ (90)
Unallocated research and development expenses (406) (259)
Unallocated selling, general and administrative expenses (178) (117)
Unallocated interest expense (142) (147)
Unallocated investment and other income, net 71  82 
Nonreportable segments (14) (15)
$ (743) $ (546)
Reconciling items for reportable segments - EBT
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months Ended
December 27,
2020		 December 29,
2019
Revenues
Nonreportable segments $ 33  $ 35 
$ 33  $ 35 
EBT
Unallocated cost of revenues $ (74) $ (90)
Unallocated research and development expenses (406) (259)
Unallocated selling, general and administrative expenses (178) (117)
Unallocated interest expense (142) (147)
Unallocated investment and other income, net 71  82 
Nonreportable segments (14) (15)
$ (743) $ (546)